All news

About 1,000 volunteers receive first dose of EpiVacCorona vaccine

All volunteers are in good health without any complications, the watchdog head said

ST. PETERSBURG, December 9. /TASS/. About 1,000 volunteers have received the first component of the EpiVacCorona vaccine against the coronavirus within the framework of post-registration trials, they have no health complaints, Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing Anna Popova reported on Wednesday.

"To date, about 1,000 people within the framework of post-registration clinical trials have already received the vaccine. All trials are going well, all volunteers are in good health without any complications, without any additional superfluous sensations," she said at an international scientific and practical conference on counteracting the novel coronavirus infection and other infectious diseases.

On July 24, the Vector State Research Center of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing obtained the Healthcare Ministry’s permit to conduct clinical trials of its vaccine on volunteers. They were completed on September 30. On October 14, Russian President Vladimir Putin reported that the vaccine developed by the Vector State Research Center has obtained the registration certificate. On November 16, the Healthcare Ministry issued a permit to conduct post-registration trials of the Center’s EpiVacCorona vaccine against the coronavirus on volunteers over the age of 60 and on November 18 - a permit for trials on 3,000 volunteers.